OncoTreat for Pancreatic Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Pancreatic CancerOncoTreat - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This study is evaluating whether a new treatment approach may help patients with advanced pancreatic cancer.

Eligible Conditions
  • Pancreatic Cancer

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 36 months

36 months
Number of participants assigned therapy with OncoTreat

Trial Safety

Trial Design

2 Treatment Groups

Observation Arm
1 of 2
Intervention Arm
1 of 2

Active Control

Experimental Treatment

30 Total Participants · 2 Treatment Groups

Primary Treatment: OncoTreat · No Placebo Group · N/A

Intervention Arm
Device
Experimental Group · 1 Intervention: OncoTreat · Intervention Types: Device
Observation ArmNoIntervention Group · 1 Intervention: Observation Arm · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 36 months

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,295 Previous Clinical Trials
1,613,241 Total Patients Enrolled
Rachael A. Safyan, MDPrincipal InvestigatorColumbia University
1 Previous Clinical Trials
31 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: